Research ArticleBrief Communication
Optimization of Hapten-Peptide Labeling for Pretargeted ImmunoPET of Bispecific Antibody Using Generator-Produced 68Ga
Habibe Karacay, Robert M. Sharkey, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang and David M. Goldenberg
Journal of Nuclear Medicine April 2011, 52 (4) 555-559; DOI: https://doi.org/10.2967/jnumed.110.083568
Habibe Karacay
Robert M. Sharkey
William J. McBride
Edmund A. Rossi
Chien-Hsing Chang

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 52, Issue 4
April 1, 2011
Optimization of Hapten-Peptide Labeling for Pretargeted ImmunoPET of Bispecific Antibody Using Generator-Produced 68Ga
Habibe Karacay, Robert M. Sharkey, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, David M. Goldenberg
Journal of Nuclear Medicine Apr 2011, 52 (4) 555-559; DOI: 10.2967/jnumed.110.083568
Optimization of Hapten-Peptide Labeling for Pretargeted ImmunoPET of Bispecific Antibody Using Generator-Produced 68Ga
Habibe Karacay, Robert M. Sharkey, William J. McBride, Edmund A. Rossi, Chien-Hsing Chang, David M. Goldenberg
Journal of Nuclear Medicine Apr 2011, 52 (4) 555-559; DOI: 10.2967/jnumed.110.083568
Jump to section
Related Articles
Cited By...
- Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer
- Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement